Women with epilepsy present health care providers with unique problems and
opportunities for advancement of care. The fundamentals of epileptic pathop
hysiology are similar in both sexes. There are, however, some significant d
ifferences. Cosmetic effects of antiepileptic drugs (AEDs) may have differe
nt implications for women. Women who have seizures associated with their me
nstrual cycle may need special attention regarding their cyclic hormonal ch
anges and AED selection. Antiepileptic drugs may reduce the effectiveness o
f hormonal contraception. Women with epilepsy have higher rates of infertil
ity and an increased prevalence of reproductive and endocrine disorders. Th
e majority of women with epilepsy have normal, healthy children, but their
pregnancies are considered high risk due to an increase in seizure frequenc
y, metabolic alterations of AEDs (which complicate management), and an incr
eased risk of adverse pregnancy outcomes. These issues and an approach to o
ptimize the management of women with epilepsy are discussed.